TrialCancer immunology, immunotherapy : CII2016

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.

Julia M Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.